The Paediatric Clinical Trials Conference - When designing a paediatric clinical trial
When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children.
Join the likes of Amgen, AstraZeneca, European Medicines Agency, GSK, MHRA, Pfizer, Roche, University of Liverpool and many more at the industry's leading paediatric clinical trials event to where Paediatric Investigation Plans (PIP) will be one focus, along with a closer look at some of the other trending topics facing the market.
There will be coverage of PIP in the Keynote Session on Day 1 at 16.00, which is hosted by Mark Turner, Chair European Network of Paediatric Research, Senior Lecturer in Neonatal Medicine at the European Medicines Agency and University of Liverpool.
There will also be a Panel Discussion about the effects PIP's had on quality of paediatric clinical trials and has this translated into greater efficiency in access to new approved medicines. This will be at 16.40 on Day 1 in the Panel Debate titled - Paediatric Medicine Regulation in the EU: What are the Challenges and Opportunities 10 Years on
Lastly, there is the conference Workshop - This year's event contains a workshop on the 21st March 2018 covering a number of areas, including a look at: Do I Need a PIP, What Should the PIP Cover, Procedures and Rewards. The Workshop will be hosted by Genevieve Michaux, Member of the Brussels and Paris Bar, Partner at Mayer Brown Europe-Brussels LLP.
For the latest news, information and for easy registration, please visit the event website: https://www.smi-
19th and 20th March 2018 / Copthorne Tara Hotel, London